Fresenius SE & Co. KGaA (ETR:FRE)
45.08
+1.22 (2.78%)
Oct 16, 2026, 5:35 PM CET
Fresenius SE & Co. KGaA Employees
Fresenius SE & Co. KGaA had 178,486 employees as of June 30, 2026. The number of employees increased by 2,279 or 1.29% compared to the same quarter last year. That makes Fresenius SE & Co. KGaA the 128th largest employer in the world and 5th in Germany.
Employees
178,486
Change
2,279
Growth
1.29%
Revenue / Employee
€130,436
Profits / Employee
€8,527
Market Cap
25.39B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 178,486 | 2,279 | 1.29% | 178,486 | 0 |
| Mar 31, 2026 | 177,783 | 2,581 | 1.47% | 177,783 | 0 |
| Dec 31, 2025 | 178,583 | -1,301 | -0.72% | 131,789 | 46,794 |
| Sep 30, 2025 | 177,356 | 265 | 0.15% | 177,356 | 0 |
| Jun 30, 2025 | 176,207 | 436 | 0.25% | 176,207 | 0 |
| Mar 31, 2025 | 175,202 | -15,661 | -8.21% | 175,202 | 0 |
| Dec 31, 2024 | 179,884 | -13,981 | -7.21% | 132,542 | 47,342 |
| Sep 30, 2024 | 177,091 | -16,436 | -8.49% | 177,091 | 0 |
| Jun 30, 2024 | 175,771 | -139,462 | -44.24% | 175,771 | 0 |
| Mar 31, 2024 | 190,863 | -122,949 | -39.18% | 190,863 | 0 |
| Dec 31, 2023 | 193,865 | -123,055 | -38.83% | 193,865 | 0 |
| Sep 30, 2023 | 193,527 | -126,164 | -39.46% | 193,527 | 0 |
| Jun 30, 2023 | 315,233 | -3,414 | -1.07% | 315,233 | 0 |
| Mar 31, 2023 | 313,812 | -3,430 | -1.08% | 313,812 | 0 |
| Dec 31, 2022 | 316,920 | 842 | 0.27% | 316,920 | 0 |
| Sep 30, 2022 | 319,691 | 4,839 | 1.54% | 319,691 | 0 |
| Jun 30, 2022 | 318,647 | 5,913 | 1.89% | 318,647 | 0 |
| Mar 31, 2022 | 317,242 | 6,400 | 2.06% | 317,242 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius Medical Care AG | 107,226 |
| Bayer Aktiengesellschaft | 87,830 |
| Siemens Healthineers AG | 74,300 |
| Merck KGaA | 62,136 |
| Fielmann Group AG | 18,928 |
| Drägerwerk AG & Co. KGaA | 16,009 |
| Sartorius Aktiengesellschaft | 14,279 |
| Ottobock SE & Co. KGaA | 9,406 |
Fresenius SE & Co. KGaA News
- 1 day ago - Fresenius Names Mahl To Management Board, Extends CFO Hennicken's Contract - Nasdaq
- 1 day ago - Fresenius Extends CFO Sara Hennicken Contract For Another 5 Years - Finanz Nachrichten
- 16 days ago - Fresenius Acquires Remaining 45% Stake In MAbxience For Up To EUR 750 Mln - Nasdaq
- 17 days ago - Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now? - Nasdaq
- 18 days ago - Waltz Health and Fresenius Kabi Expand Direct Access to Biosimilars Through Waltz Connect Platform - PRNewsWire
- 4 weeks ago - mAbxience, Sandoz sign collaboration agreement for biosimilar access - TheFly
- 2 months ago - Fresenius SE price target raised to EUR 52 from EUR 49 at Morgan Stanley - TheFly
- 2 months ago - Fresenius SE price target lowered to EUR 55.20 from EUR 56.60 at JPMorgan - TheFly